AI/ML device compliance

Plan your AI model updates before you submit.

We work with your data science and regulatory teams on the U.S. Food and Drug Administration (FDA) AI/ML guidance, predetermined change control plans (PCCPs), AI risk, and ISO/IEC 42001.

In short

What does AI/ML medical device compliance involve?

It involves planning how your AI model will change before you submit, managing AI risk inside your ISO 14971 process, and governing AI across your organization. For planned model changes, the plan is a predetermined change control plan (PCCP).

MedDev Solutions drafts the PCCP, the AI risk analysis, and the premarket documentation with your data science and regulatory teams, and implements ISO/IEC 42001, designed to support compliance with that standard.

Sound familiar?

Every delay, handoff, and miscommunication pushes your FDA timeline further out.

AI adds handoffs. Here is one planned model change, without a plan agreed in advance and with one.

The handoffRetrained model to release

Without a PCCP
  • Your data scientists retrain a model.
  • Regulatory decides whether the change needs a new submission.
  • Quality documents it. Risk management checks what changed.
With a PCCP
  • The change is checked against your PCCP and risk file first.
  • Validation runs the way the plan says.
  • Documentation updates in the same sprint.
  • Planned updates don't need a new submission each time.

How we work with your team

Inside your model pipeline, not after it.

Your regulatory team sees each change before it ships, not after. Here is who does what.

  1. 01What FDA reviews

    The AI functions in your device, and how they will change.

    FDA reviews the AI functions in this device. A PCCP is a plan agreed with FDA before market that defines which changes you may make after market and how they are validated.

  2. 02What we prepare

    The plan, the risk analysis, and the documentation.

    We draft the PCCP, the AI risk analysis inside your ISO 14971 process, and the premarket documentation with your data science and regulatory teams.

  3. 03What your team owns

    Your team keeps every model decision.

    Your data scientists get validation methods and change limits written before they retrain. Your company remains the manufacturer and keeps responsibility for its design controls and submission.

What we deliver

What do we deliver, for the device and the organization?

FDA reviews the AI functions in this device. ISO/IEC 42001 looks at how your organization governs AI across every product. We cover both levels.

For your AI-enabled device

The plan, risk analysis, and documentation for the AI functions in your device software.

  • A PCCP drafted with your data science and regulatory teams
  • AI risk management for Software as a Medical Device (SaMD) inside your ISO 14971 process
  • AI-specific risks, such as automation bias, out-of-distribution inputs, and data poisoning
  • A record for third-party foundation models and large language models (LLMs): provenance, version history, update cadence, and output variability
  • A PCCP section for your premarket submission, structured to FDA's PCCP guidance

For your organization

The process that governs AI across your products, from planning to retirement.

  • ISO/IEC 42001:2023 implementation, designed to support compliance with the standard for AI management systems
  • Your development process mapped to FDA's AI/ML guidance
  • Post-market plans that separate operations monitoring (logging, alerting, drift detection) from real-world performance evaluation
  • EU AI Act readiness, for teams also selling into the EU

How an engagement runs

How does an engagement run?

In five phases, scoped to your AI functions. Timing depends on your model, your pathway, and where you start. We scope the work with you on the first call.

  1. Assess

    We map the AI functions in your software against FDA's AI/ML guidance and ISO/IEC 42001, and list the gaps in the order your submission needs them closed.

  2. Plan

    AI risk analysis and a draft PCCP, built with your data science and regulatory teams.

  3. Build

    Validation methods, documentation, and your AI management system, set up with your team.

  4. Prepare

    Premarket documentation for your AI functions, written with your regulatory team.

  5. Maintain

    Model changes that fall within your PCCP run under it. Changes outside it go to your regulatory team for a submission decision. Monitoring and real-world performance evaluation feed back into your risk file.

Questions we get

AI/ML compliance FAQ

Answer

MedDev Solutions

We connect the two: risk analysis, PCCP, validation methods, and documentation that describe the same model at the same version. Your data scientists know the model and your regulatory lead knows the pathway. Your team keeps every model decision. Your company remains the manufacturer and keeps responsibility for its design controls and submission.

MedDev Solutions

It depends on how often and how far you plan to change your model after market. We work that out with you, and if a PCCP fits, we draft it with your regulatory team.

MedDev Solutions

No. ISO/IEC 42001:2023 is the first international standard for AI management systems. It covers how your organization governs AI. FDA's PCCP guidance covers predetermined change control plans for your device. We work to both.

MedDev Solutions

You need a record of the model you depend on: provenance, version history, update cadence, and output variability. FDA's discussion paper on generative AI-enabled devices (August 2026, not guidance) notes that changes to the underlying model may be initiated by the foundation model developer rather than the device manufacturer. We build that record with you.

MedDev Solutions

No. We can't promise any regulatory outcome. We deliver the risk analysis, the plan, and the documentation, built with your team and traced to FDA's PCCP guidance.

MedDev Solutions

Yes, as EU AI Act readiness for teams also selling into the EU. Under the AI Act (EU) 2024/1689, medical AI that goes through a Notified Body conformity assessment under EU Medical Device Regulation (MDR) 2017/745 is treated as high-risk, with a single combined assessment.

Something else? Ask us directly on a 30-minute call

Next step

Bring your model change plans.We'll map them with you.

In 30 minutes, we'll walk through the AI in your software, your submission plan, and how FDA's AI/ML guidance and ISO/IEC 42001 apply. We'll suggest a first step.